Advertisement
Correspondence| Volume 71, ISSUE 11, e43-e44, June 01, 2012

Download started.

Ok

Is Deep Brain Stimulation Able to Make Antidepressants Effective in Resistant Obsessive-Compulsive Disorder?

Published:November 24, 2011DOI:https://doi.org/10.1016/j.biopsych.2011.10.013
      Deep brain stimulation (DBS), a nonablative, reversible, and adjustable neurosurgical procedure, has recently been considered as a potential therapeutic alternative for the management of resistant obsessive-compulsive disorder (OCD). The ventral striatum (VS) has been proposed as a subcortical target of special interest for DBS (
      • Nuttin B.
      • Cosyns P.
      • Demeulemeester H.
      • Gybels J.
      • Meyerson B.
      Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder.
      ,
      • Aouizerate B.
      • Martin-Guehl C.
      • Cuny E.
      • Guehl D.
      • Amieva H.
      • Benazzouz A.
      • et al.
      Deep brain stimulation for OCD and major depression.
      ,
      • Aouizerate B.
      • Cuny E.
      • Bardinet E.
      • Yelnik J.
      • Martin-Guehl C.
      • Rotge J.Y.
      • et al.
      Distinct striatal targets in treating obsessive-compulsive disorder and major depression.
      ,
      • Denys D.
      • Mantione M.
      • Figee M.
      • van den Munckhof P.
      • Koerselman F.
      • Westenberg H.
      • et al.
      Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.
      ,
      • Greenberg B.D.
      • Gabriels L.A.
      • Malone Jr, D.A.
      • Rezai A.R.
      • Friehs G.M.
      • Okun M.S.
      • et al.
      Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.
      ). It has been extensively demonstrated to play a major role in the pathophysiology of OCD regarding convergent functional neuroimaging data and electrophysiologic recordings (
      • Aouizerate B.
      • Guehl D.
      • Cuny E.
      • Rougier A.
      • Bioulac B.
      • Tignol J.
      • et al.
      Pathophysiology of obsessive-compulsive disorder: A necessary link between phenomenology, neuropsychology, imagery and physiology.
      ,
      • Rotge J.Y.
      • Guehl D.
      • Dilharreguy B.
      • Cuny E.
      • Tignol J.
      • Bioulac B.
      • et al.
      Provocation of obsessive-compulsive symptoms: A quantitative voxel-based meta-analysis of functional neuroimaging studies.
      ,
      • Guehl D.
      • Benazzouz A.
      • Aouizerate B.
      • Cuny E.
      • Rotge J.Y.
      • Rougier A.
      • et al.
      Neuronal correlates of obsessions in the caudate nucleus.
      ,
      • Haynes W.I.
      • Mallet L.
      High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit.
      ). Here, we report the long-term course of OC symptoms during DBS of the VS and following its discontinuation in two patients suffering from severe, chronic, and incapacitating OCD and showing unsatisfactory responses to 1) the serotonin reuptake inhibitor (SRI) antidepressants fluoxetine, sertraline, paroxetine, fluvoxamine, and clomipramine; 2) augmentation with buspirone or lithium; and 3) adjunctive cognitive-behavioral therapy (
      • Aouizerate B.
      • Martin-Guehl C.
      • Cuny E.
      • Guehl D.
      • Amieva H.
      • Benazzouz A.
      • et al.
      Deep brain stimulation for OCD and major depression.
      ,
      • Aouizerate B.
      • Cuny E.
      • Bardinet E.
      • Yelnik J.
      • Martin-Guehl C.
      • Rotge J.Y.
      • et al.
      Distinct striatal targets in treating obsessive-compulsive disorder and major depression.
      ). The standard instrument Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was used to assess clinical severity (
      • Goodman W.K.
      • Price L.H.
      • Rasmussen S.A.
      • Mazure C.
      • Fleischmann R.L.
      • Hill C.L.
      • et al.
      The Yale-Brown Obsessive Compulsive Scale I. Development, use, and reliability.
      ). Written informed consent was obtained after the study had been fully explained.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nuttin B.
        • Cosyns P.
        • Demeulemeester H.
        • Gybels J.
        • Meyerson B.
        Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder.
        Lancet. 1999; 354: 1526
        • Aouizerate B.
        • Martin-Guehl C.
        • Cuny E.
        • Guehl D.
        • Amieva H.
        • Benazzouz A.
        • et al.
        Deep brain stimulation for OCD and major depression.
        Am J Psychiatry. 2005; 162: 2192
        • Aouizerate B.
        • Cuny E.
        • Bardinet E.
        • Yelnik J.
        • Martin-Guehl C.
        • Rotge J.Y.
        • et al.
        Distinct striatal targets in treating obsessive-compulsive disorder and major depression.
        J Neurosurg. 2009; 111: 775-779
        • Denys D.
        • Mantione M.
        • Figee M.
        • van den Munckhof P.
        • Koerselman F.
        • Westenberg H.
        • et al.
        Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder.
        Arch Gen Psychiatry. 2010; 67: 1061-1068
        • Greenberg B.D.
        • Gabriels L.A.
        • Malone Jr, D.A.
        • Rezai A.R.
        • Friehs G.M.
        • Okun M.S.
        • et al.
        Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.
        Mol Psychiatry. 2010; 15: 64-79
        • Aouizerate B.
        • Guehl D.
        • Cuny E.
        • Rougier A.
        • Bioulac B.
        • Tignol J.
        • et al.
        Pathophysiology of obsessive-compulsive disorder: A necessary link between phenomenology, neuropsychology, imagery and physiology.
        Prog Neurobiol. 2004; 72: 195-221
        • Rotge J.Y.
        • Guehl D.
        • Dilharreguy B.
        • Cuny E.
        • Tignol J.
        • Bioulac B.
        • et al.
        Provocation of obsessive-compulsive symptoms: A quantitative voxel-based meta-analysis of functional neuroimaging studies.
        J Psychiatry Neurosci. 2008; 33: 405-412
        • Guehl D.
        • Benazzouz A.
        • Aouizerate B.
        • Cuny E.
        • Rotge J.Y.
        • Rougier A.
        • et al.
        Neuronal correlates of obsessions in the caudate nucleus.
        Biol Psychiatry. 2008; 63: 557-562
        • Haynes W.I.
        • Mallet L.
        High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit.
        Eur J Neurosci. 2010; 32: 1118-1127
        • Goodman W.K.
        • Price L.H.
        • Rasmussen S.A.
        • Mazure C.
        • Fleischmann R.L.
        • Hill C.L.
        • et al.
        The Yale-Brown Obsessive Compulsive Scale.
        Arch Gen Psychiatry. 1989; 46: 1006-1011
        • Albert U.
        • Aguglia E.
        • Maina G.
        • Bogetto F.
        Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12-week, controlled study.
        J Clin Psychiatry. 2002; 63: 1004-1009
        • Pallanti S.
        • Quercioli L.
        Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines.
        Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30: 400-412
        • Kellner C.H.
        • Knapp R.G.
        • Petrides G.
        • Rummans T.A.
        • Husain M.M.
        • Rasmussen K.
        • et al.
        Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
        Arch Gen Psychiatry. 2006; 63: 1337-1344
        • Van den Broek W.W.
        • Birkenhager T.K.
        • Mulder P.G.
        • Bruijn J.A.
        • Moleman P.
        Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial.
        J Clin Psychiatry. 2006; 67: 263-268
        • Hollander E.
        • Friedberg J.
        • Wasserman S.
        • Allen A.
        • Birnbaum M.
        • Koran L.M.
        Venlafaxine in treatment-resistant obsessive-compulsive disorder.
        J Clin Psychiatry. 2003; 64: 546-550
        • Denys D.
        • van Megen H.J.
        • van der Wee N.
        • Westenberg H.G.
        A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
        J Clin Psychiatry. 2004; 65: 37-43
        • Rush A.J.
        • Trivedi M.H.
        • Wisniewski S.R.
        • Nierenberg A.A.
        • Stewart J.W.
        • Warden D.
        • et al.
        Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report.
        Am J Psychiatry. 2006; 163: 1905-1919